By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Norgine 

Hogehilweg 7
1101 CA
Amsterdam Zuid-Oost      The Netherlands
Phone: 31-20-567-0900 Fax: 31-20-567-0999


SEARCH JOBS


Industry
Pharmaceutical






Company News
Valeant (VRX) Announces Licensing Agreement With Norgine For NER1006 In U.S. And Canada 8/8/2016 6:55:18 AM
Norgine Release: New Positive Phase III Study For NER1006 - The First 1 Litre PEG-Based Bowel Preparation 5/24/2016 12:00:08 PM
Norgine Presents Phase III Study Design For NER1006, Its Low-Volume Bowel Cleansing Solution, At United European Gastroenterology Week 2015 10/27/2015 7:24:16 AM
Norgine Release: Positive Phase III Top Line Results Demonstrate Efficacy Of NER1006, A Novel, Low Volume Bowel Preparation, Vs. Trisulfate 10/9/2015 6:55:12 AM
Norgine And Arc Medical Announce Partnership For Endoscopic Device, ENDOCUFF VISION 3/12/2015 6:51:49 AM
Navidea Biopharmaceuticals (NAVB) And Norgine Enter European Commercial Partnership For Lymphoseek; Navidea To Receive $2 Million Upfront Payment 3/5/2015 11:01:23 AM
PlasmaTech Biopharmaceuticals Signs Expanded MuGard Licensing Agreement With Norgine For Australia And New Zealand Territories 10/27/2014 8:24:29 AM
Norgine Release: Positive Results From Phase 2 Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 10/20/2014 7:39:25 AM
Norgine Enrolls First Patient In The Phase 3 NOCT Study To Evaluate Bowel Cleansing Efficacy Of NER1006, A Novel, Low Volume Bowel Preparation, Vs. Trisulfate 10/3/2014 7:25:39 AM
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014 7:50:59 AM
123
//-->